Medical Devices

Image

Global Cervix Conization Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cervix Conization Market, By Disease Indication (Pre-malignant lesions- Cervical Intraepithelial Neoplasia, Early invasive stage, Advanced invasive stage), Age Group (20 to 35 years, Above 35 years), End-User (Hospitals, Diagnostic centers, Cancer Palliative care clinics, Pharmacies) – Industry Trends and Forecast to 2029

Cervix Conization Market

Cervix Conization Market Analysis and Size

The cervix conization market is expected to witness significant growth during the forecast period. According to global cancer statistics, nearly 80% of women's cases of cervical cancer occur in resource-poor developing countries. By the end of 2018, about 13,240 new cases of invasive cervical cancer will be diagnosed in the United States, and about 4,170 women will die of cervical cancer, according to the American Cancer Society. A good recovery approach is another important factor expected to support the number of screening tests in the estimated time frame. In addition, innovation is important in promoting accessibility and moderation of various analytical tests in the United States.

Data Bridge Market Research analyses a growth rate in the cervix conization market in the forecast period 2022-2029. The cervix conization market is expected to have a healthy CAGR in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Cervical conization, or cold knife cone (CKC), is a surgical procedure used to diagnose and treat cervical dysplasia, or very early stage cervical cancer. This involves removing the conical portion of the cervix to remove the cervical lesion along with the entire deformed zone. There are many indications for this procedure. Conflicts between Papanicolaou stain and biopsy findings, significantly milder histological findings than cytological findings, evidence of severe dysplasia, and presence of stage 1A1 squamous cell carcinoma.

Cervix Conization Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

isease Indication (Pre-malignant lesions- Cervical Intraepithelial Neoplasia, Early invasive stage, Advanced invasive stage), Age Group (20 to 35 years, Above 35 years), End-User (Hospitals, Diagnostic centers, Cancer Palliative care clinics, Pharmacies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott (U.S.), Arbor Vita Corporation (U.S.), BD (U.S.), CooperSurgical Inc. (U.S.), F. Hoffmann-La Roche AG (U.S.), Guided Therapeutics Inc. (U.S.), Hologic Inc. (U.S.), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare GmbH (Germany)

Market Opportunities

  • Adoption of immunotherapy and targeted therapies
  • Advanced clinical research and technological advancement

Global Cervix Conization Market Dynamics

Drivers

  • Increasing Cervical Cancer

According to global cancer statistics, nearly 80% of women's cases of cervical cancer occur in resource-poor developing countries. Aside from lack of awareness, the difficulty of conducting cytopathological-based screening programs also plays a major role in delaying the treatment of cervical cancer in such economies, including India. Medical professionals attach great importance to robust pre-screening protocols that are essential for detecting early changes in the cervical epithelium.

  • Rising Awareness of Cancer

The rising awareness about early diagnosis of cervical cancer is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. 

Opportunities

  • Adoption of Immunotherapy and Targeted Therapies

Immune-based therapies are touted as the most promising alternative therapies to prevent, treat, and treat cancer. Oncologists and medical professionals are expected to study immunotherapy's effectiveness in treating cervical cancer. These include checkpoint inhibitors that block the ability of cancer cells to damage the immune system and therapeutic vaccines that elicit a response to cancer cells. For instance, Axalimogene Filolisbac, which has already been studied in six clinical trials, is touted as the most unique immunotherapy for HPV-related cancers.

  • Advanced Clinical Research and Technological Advancement

Increased clinical research and technological advancements are leading to market growth. The Curie Institute recently launched a new clinical trial called NiCOL focused on patients suffering from late-stage cervical cancer. With the aim of determining the optimal dose of nivolumab, a monoclonal antibody, researchers will evaluate the clinical efficacy of NiCOL, as well as the immunological and genetic mechanisms at the stage of pelvic chemoradiation therapy. On the other hand, Iovance Biotherapeutics, Inc, is a self-tumor infiltrating lymphocyte (TIL) LN-145 with the aim of providing recurrent metastatic and persistent, a second-line option for the treatment of cervical cancer.

Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified personnel who are unable to diagnose and treat the disease could curb the growth of the global cervix conization market over a forecast period.

  • High cost

The huge expenditure required for diagnosing and treating the cervix cancer surely hamper the market growth.

This cervix conization market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cervix conization market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Cervix Conization Market

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. COVID-19 causes pneumonia, severe and acute respiratory illness, multiple organ failure, and, in severe cases, death. Older populations are more vulnerable to COVID-19. The pandemic killed about 342,000 women from cervical cancer in 2020.

In the post-pandemic era, COVID-19 is expected to positively impact the global cervix conization market, attributing to the increasing number of cervical cancer cases.

Global Cervix Conization Market Scope

The l cervix conization market is segmented on the basis of disease indication, age group and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disease Indication

  • Pre-malignant lesions
  • Early invasive stage
  • Advanced invasive stage

Age Group

  • 20 to 35 years
  • Above 35 years

End User

  • Hospitals
  • Diagnostic centers
  • Cancer Palliative care clinics
  • Pharmacies.

 Cervix Conization Market Regional Analysis/Insights

The cervix conization market is analysed and market size insights and trends are provided by disease indication, age group and end-user as referenced above.

The major countries covered in the cervix conization market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market in the forecast period due to the presence of key companies offering cervical cancer treatment, technological advancements, and increased number of health care centers.

Asia-Pacific is considered to have the most lucrative period due to the rise in cervical cancer prevalence and increased awareness in countries in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Cervix Conization Market Share Analysis

The cervix conization market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cervix conization market.

Key players operating in the cervix conization market include:

  • Abbott (U.S.)
  • Arbor Vita Corporation (U.S.)
  • BD (U.S.)
  • CooperSurgical Inc. (U.S.)
  • F. Hoffmann-La Roche AG (U.S.)
  • Guided Therapeutics Inc. (U.S.)
  • Hologic Inc. (U.S.)
  • QIAGEN (Germany)
  • Quest Diagnostics Incorporated (U.S.)
  • Siemens Healthcare GmbH (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Factors such as rising demand for blood and blood components and economic-friendly nature are acting as the major drivers for the cervix conization market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials